Editorial and research standards
How Inside Telehealth researches the market.
Our method covers company profiles, comparisons, reporting, and datasets built from dated evidence. It separates what a company says from what a source establishes, preserves uncertainty, and gives large and small providers the same core verification standard.
Method effective September 3, 2026. A page may add a narrower method when its research question requires one.
01
Coverage and inclusion
We cover organizations that deliver or materially enable virtual clinical care, along with ownership changes, regulation, technology, and market events that help explain them. National platforms provide market context, while smaller, specialty, regional, and emerging organizations are an intentional coverage priority.
We choose coverage for reader and research value—not because a company paid, linked to us, or supplied favorable access. A listing or outbound link is not an endorsement. Providers may submit their organization for consideration, but submissions enter the same review process as editor-selected companies.
02
Source hierarchy
We seek the source closest to the fact and preserve its publisher, document date when available, access date, and durable identifier or archive when useful. We generally prioritize:
- Regulators, courts, government records, corporate filings, and licensing records
- Peer-reviewed research, recognized standards, and original datasets
- Official company terms, pricing pages, policies, press releases, and direct on-the-record responses
- Reputable third-party reporting with transparent attribution
- Secondary directories, reviews, or user reports only as leads or clearly limited context
A first-party page is often authoritative for what a company currently advertises; it is not independent proof that a clinical, operational, or comparative claim is true. Consequential claims should link to the evidence beside the claim and appear in the page's consolidated source list.
03
Evidence labels
These labels keep attribution and uncertainty visible. They do not turn weak evidence into strong evidence.
Verified fact
A claim supported by the cited primary or otherwise authoritative source. This does not mean we independently reproduced the underlying result.
Company says
A first-party assertion that we can attribute but have not independently established.
Inside Telehealth analysis
A conclusion derived from named inputs using the method described on the page.
Unknown
Relevant information that we could not verify or that was not publicly available.
04
Company and availability verification
A company profile begins with identity: current and legal names, aliases, official domain, operating status, ownership, and material history. We then research care areas, delivery model, clinician and fulfillment relationships, eligibility, payment options, and availability. Ambiguous marketing language such as “our doctors” or “our pharmacy” is not enough to infer a legal or operational relationship.
Availability is recorded for a named jurisdiction and scope—company, care area, service line, or product—with a status, attribution, supporting source, observation date, and planned review date where structured records exist. “Nationwide” does not establish that every service is available to every patient in every state.
05
Dates and freshness
- Published
- When the page first became public.
- Updated
- When its substantive editorial content last changed.
- Last checked
- When a page's changeable core facts were last checked. Each page shows one Updated date in its header; when the check date differs it appears with the page's sources, and every provider row and source keeps its own observation date.
- Observed or effective
- When a price, availability state, rule, or event was seen or applied.
We do not refresh a date merely to make a page appear current. Volatile facts are rechecked when a page is materially updated, and stale or contradictory evidence is disclosed rather than silently reconciled.
06
Pricing and insurance
We separate consultation, membership, medication, laboratory, shipping, introductory, renewal, and cancellation costs. A “starting at” price is not treated as a complete cost. Each comparison must identify the unit, cadence, observation date, required components, exclusions, and whether a price is advertised, observed during checkout, estimated, or supplied by the company.
Insurance support can mean several different things: an in-network visit, a claim a patient submits, coverage for a particular medication or laboratory, or an employer or health-plan benefit. We state which arrangement the evidence supports and mark unknown patient-specific cost as variable.
07
Comparison method
Before comparing organizations, we define the decision, population, geography, time period, eligibility rules, and fields being compared. The same definitions and evidence threshold apply to every company. Missing data stays missing; we do not convert silence into a zero, a negative, or an advantage.
We explain material tradeoffs and who each option may fit rather than naming a universal winner without a published, reproducible scoring method and adequate evidence. Pairwise pages are created only for a genuine reader decision—not every possible company combination.
08
Editorial review and accountability
Before publication, we check citation support, source dates, company identity, omissions, consistency, tone, and relevant disclosures. Material factual claims must trace to cited evidence.
The editor resolves material findings and approves publication. Inside Telehealth reports publicly documented facts and makes no clinical claims: our pages say what companies, regulators, courts, and public filings say, and do not characterize the efficacy, safety, dosing, suitability, or outcomes of any treatment. Any page that ever needs to make a clinical claim must declare it and carry a qualified human medical review. Our disclosures describe ownership and commercial relationships.
09
Provider input and limitations
Companies may provide documents, answer factual questions, and identify missing context. Supplying material grants no approval rights over our draft or conclusion. We evaluate supplied evidence by the same standard as independently located evidence and disclose a material relationship or access condition where relevant.
Readers and covered organizations may send source material or evidence of an error to editor@insidetelehealth.org.
Public information can be incomplete, stale, or ambiguous. Unless a page says otherwise, we have not purchased or clinically tested the service, independently reproduced a company's result, or determined what care is appropriate for an individual. Inside Telehealth is a publication, not a healthcare provider.